The NCCN has updated guidelines for genetic testing for breast, ovarian, and pancreatic cancer, with a new list of high- to moderate-penetrance genes and a new section on pancreatic cancer.
Rachel Darwin, Senior Manager, Public Relations Translations are underway for the entire library of NCCN Guidelines for Patients to empower people with cancer and caregivers…
This webinar series provides an opportunity for a varied group of global stakeholders to highlight and discuss global challenges to equitable and high-quality cancer care,…
Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.
Rachel Darwin, Senior Manager, Public Relations Speakers at the National Comprehensive Cancer Network’s event discussed the importance of diversity, equity, and inclusion (DEI) as integral…
3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462 Phone: 215-690-0300 Fax: 215-690-0280 Copyright © National Comprehensive Cancer Network, All Rights Reserved. No portion of…
Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.
Rachel Darwin, Senior Manager, Public Relations Researchers found that omitting the bolus-specific 5-flourouracil (5-FU) portion from common chemotherapy regimens could improve tolerability for patients without…
Register now! Measuring and Addressing Health-Related Social Needs in Cancer Tuesday, September 12, 2023 National Press Club, Washington, D.C. | Virtual attendance also available Navigating…
Annual Congress: Hematologic Malignancies features presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematologic malignancies.
3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462 Phone: 215-690-0300 Fax: 215-690-0280 Copyright © National Comprehensive Cancer Network, All Rights Reserved. No portion of…
